|
(MoneyNewsWire.Net, May 09, 2018 ) The North America Preclinical in-vivo imaging market has been estimated at USD 261.8 Million in 2016 and is projected to reach USD 346.4 Million by 2022, at a CAGR of 4.90% during the forecast period from 2016 to 2022. Preclinical in-vivo imaging modalities are very crucial for researchers in observing changes, either at the organ, tissue, cell, or molecular level, responding to physiological or environmental changes. It helps in gaining greater understanding of disease and therapeutic efficacy.
Browse market data tables and in-depth TOC of the North America Preclinical In-vivo Imaging Market to 2022 @ https://www.marketdataforecast.com/market-reports/north-america-preclinical-in-vivo-imaging-market-583/
The factors such as development of technologically advanced hybrid preclinical imaging systems such as PET/CT, PET/MRI, and PET/SPECT/CT, and growing acceptance of preclinical imaging as a legitimate drug development tool are the driving the market for Preclinical in-vivo imaging in North America. Declining NIH (National Institutes of Health) funding for life science research is constraining the market growth in this region.
North America market for Preclinical In-vivo Imaging is segmented based on Modality and Reagents. Based on modality, the North America preclinical imaging market is divided into seven major segments, namely, optical imaging, nuclear imaging, micro-MRI, micro-CT, micro-ultrasound, photoacoustic, and magnetic particle imaging systems. The preclinical optical imaging systems market includes bioluminescence/fluorescence imaging systems, standalone fluorescence imaging systems, optical + X-ray/optical + CT imaging systems. The preclinical nuclear imaging systems market comprises micro-PET systems (standalone PET, PET/CT, and PET/MRI), micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI), and tri-modality (PET/SPECT/CT) imaging systems. Bases on the reagents, the North America preclinical imaging market is divided into five segments, namely, optical imaging reagents, nuclear imaging reagents, MRI contrast agents, ultrasound contrast agents, and CT contrast agents. The optical imaging reagents market is further sub-segmented as bioluminescent and fluorescent imaging reagents. Likewise, the nuclear imaging reagents market is divided as preclinical PET tracers and SPECT robes.
Free sample of the report is available @ https://www.marketdataforecast.com/market-reports/north-america-preclinical-in-vivo-imaging-market-583/request-sample
Geographically, North America market for Preclinical In-vivo Imaging is segmented into U.S and Canada. North America holds the largest share of the global preclinical imaging market, while, U.S holds the maximum share in North America. The preclinical imaging market in North America is primarily driven by various factors like high volume of preclinical research in this region, easy availability and accessibility of resources, and rising government funding for research and innovation in Canada.
Aspect Imaging, Biospace Lab S.A., Bruker Corporation, LI-COR Biosciences, Mediso Ltd., MILabs B.V., MR Solutions Ltd, PerkinElmer, Inc., TriFoil Imaging, and FUJIFILM VisualSonics, Inc. are the key players operating in the North America preclinical imaging systems market.
Inquire before buying @ https://www.marketdataforecast.com/market-reports/north-america-preclinical-in-vivo-imaging-market-583/inquire
The scope of the report provides:
The evaluation of the current market for your product or services and the future implications of the market
Addresses the opportunities by better understanding the market through size estimates and growth rate analysis to forecast the market for the future
Extensive segmentation to understand the dynamics of market at a very granular level by splitting down the market to the smallest segment
Addresses the key market dynamics involving the drivers, restraints and challenges with an aim of providing insights for gaining market share
The factors responsible for the shaping of the industry as it is as a result of competitive environment is analyzed through Porters Five Forces
The effects of political, economic, social, technological, legal and environmental factors on the industry is analyzed through PESTLE analysis to better understand the aspects of strategic management required to comply with the exogenous and endogenous factors
Strategic evaluation of the key players to gain insights of their performance allowing access to their product portfolio, financial performance and the strengths of their business strategic developments
Comparative study of the firms across the industry measuring their performances based on market share and recent activities in order to achieve competitive intelligence
Equip you with the information providing with the investment opportunities in the industry
Looking for more? If you are in need of a specific research study, we have an expertise in undertaking a customized study and will aid to meet your research requirement to the fullest.
Order your copy of the report: https://www.marketdataforecast.com/cart/buy-now/north-america-preclinical-in-vivo-imaging-market-583/
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail:abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
Follow us @ https://in.linkedin.com/company/market-data-forecast
Market Data Forecast.
Abhishek Shukla
+1-888-702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
|
